We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVT icon
526
Avnet
AVT
$7.92B
– –
-25,058
Closed -$1.21M
AWR icon
527
American States Water
AWR
$3.46B
– –
-3,670
Closed -$289K
DCH
528
Dauch Corp
DCH
$1.51B
– –
-33,742
Closed -$137K
AXON
529
Axon Enterprise
AXON
$46.4B
– –
-633
Closed -$333K
BAH icon
530
Booz Allen Hamilton
BAH
$9.15B
– –
-3,713
Closed -$388K
BBY icon
531
Best Buy
BBY
$17.3B
– –
-7,391
Closed -$544K
BEPC icon
532
Brookfield Renewable
BEPC
$6.26B
– –
-10,840
Closed -$303K
BIRK icon
533
Birkenstock
BIRK
$7.07B
– –
-7,461
Closed -$342K
BLBD icon
534
Blue Bird Corp
BLBD
$2.18B
– –
-7,882
Closed -$255K
BRCC icon
535
BRC Inc
BRCC
$250M
– –
-21,615
Closed -$45.2K
BRY
536
DELISTED
Berry Corp
BRY
– –
-29,721
Closed -$95.4K
BVS icon
537
Bioventus
BVS
$1.19B
– –
-18,681
Closed -$171K
BWXT icon
538
BWX Technologies
BWXT
$15.6B
– –
-4,131
Closed -$408K
BBBY
539
Bed Bath & Beyond
BBBY
$442M
– –
-13,495
Closed -$71.2K
CABO icon
540
Cable One
CABO
$212M
– –
-1,290
Closed -$343K
CALM icon
541
Cal-Maine
CALM
$3.99B
– –
-2,566
Closed -$233K
CATX icon
542
Perspective Therapeutics
CATX
$342M
– –
-15,000
Closed -$31.9K
CB icon
543
Chubb
CB
$135B
– –
-1,558
Closed -$471K
CCC
544
CCC Intelligent Solutions
CCC
$4.08B
– –
-30,269
Closed -$273K
CDNA icon
545
CareDx
CDNA
$2.42B
– –
-22,197
Closed -$394K
CENT icon
546
Central Garden & Pet Co
CENT
$2.8B
– –
-8,290
Closed -$304K
CHD icon
547
Church & Dwight Co
CHD
$24.5B
– –
-6,746
Closed -$743K
CHDN icon
548
Churchill Downs
CHDN
$6.12B
– –
-5,878
Closed -$653K
CIFR icon
549
Cipher Digital
CIFR
$7.13B
– –
-19,128
Closed -$44K
CL icon
550
Colgate-Palmolive
CL
$74.4B
– –
-8,855
Closed -$830K
20 21
22
23 24

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.